News
Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.
Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance p ...
Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance p ...
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial ... healthcare professional ...
4d
GlobalData on MSNAdicet Bio doses first SSc subject in second cohort of trial evaluating ADI-001Participants who are enrolled will be given a dose of ADI-001, followed by a 28-day dose-limiting toxicity window.
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...
Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).
Transfer news LIVE: Arsenal in Eze bid; Gyokeres official; Isak Liverpool twist; Chelsea eye Rogers; Man Utd ...
The concept of early, aggressive medical intervention to manage PsA was also discussed ... The key findings were significant improvements across multiple domains at 12 weeks. In terms of disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results